X4 Pharmaceuticals
XFOR
XFOR
96 hedge funds and large institutions have $143M invested in X4 Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.11% more ownership
Funds ownership: 1.94% → 2.04% (+0.11%)
4% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 24
Holders
96
Holding in Top 10
1
Calls
$705K
Puts
$611K
Top Buyers
| 1 | +$6.37M | |
| 2 | +$3.39M | |
| 3 | +$3.35M | |
| 4 |
Goldman Sachs
New York
|
+$1.37M |
| 5 |
Morgan Stanley
New York
|
+$839K |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$1.62M | |
| 3 | -$1.34M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$867K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$566K |